Toward predicting metastatic progression of melanoma based on gene expression data

Pigment Cell and Melanoma Research

Volumn 28, Issue 4, 2015, Pages 453-463

  Li, Yuanyuan ^a   Krahn, Juno M ^a   Flake, Gordon P ^a   Umbach, David M ^a   Li, Leping ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

Biomarker; Classification; GA KNN; Melanoma; Metastasis; Metastatic progression

Indexed keywords

CALCIUM; F2RL2 PROTEIN; KERATIN; KRT17 PROTEIN; LCE3D PROTEIN; MASP1 PROTEIN; MATRIX METALLOPROTEINASE; MICRORNA; MICRORNA 126; MICRORNA 205; MICRORNA 509; MICRORNA 514; MICRORNA 539; PROTEIN; PROTEIN S 100; PSORIASIN; S100A7A PROTEIN; STMN2 PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR E2F1; TRANSCRIPTION FACTOR PAX1; UNCLASSIFIED DRUG; WNT2 PROTEIN;

ARTICLE; CALCIUM BINDING; CANCER GROWTH; CANCER STAGING; CELL DIFFERENTIATION; CELL PROLIFERATION; CLINICAL FEATURE; COMPLEMENT ACTIVATION; COMPLEMENT INHIBITION; CONTROLLED STUDY; CUTANEOUS MELANOMA; DOWN REGULATION; ESOPHAGUS CARCINOMA; GENE EXPRESSION; GENE FREQUENCY; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; HUMAN TISSUE; KERATINIZATION; METASTATIC MELANOMA; MITOSIS RATE; PRIMARY TUMOR; PROTEIN DEGRADATION; SIGNAL TRANSDUCTION; TUMOR MICROENVIRONMENT; DISEASE COURSE; GENE EXPRESSION REGULATION; GENE ONTOLOGY; GENETICS; MELANOMA; METABOLISM; METASTASIS; PATHOLOGY; PROGNOSIS; SEQUENCE ANALYSIS; TUMOR GENE;

DISEASE PROGRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE ONTOLOGY; GENES, NEOPLASM; HUMANS; MELANOMA; MICRORNAS; NEOPLASM METASTASIS; PROGNOSIS; SEQUENCE ANALYSIS, RNA;

EID: 84930932304     PISSN: 17551471     EISSN: 1755148X     Source Type: Journal    
DOI: 10.1111/pcmr.12374     Document Type: Article

References (52)

1. Andersson, E.R., Sandberg, R., and Lendahl, U. (2011). Notch signaling: simplicity in design, versatility in function. Development 138, 3593-3612.
2. Bandarchi, B., Ma, L., Navab, R., Seth, A., and Rasty, G. (2010). From melanocyte to metastatic malignant melanoma. Dermatol. Res. Pract. 2010, 583748.
3. Bennett, D.C. (2008). How to make a melanoma: what do we know of the primary clonal events? Pigment Cell Melanoma Res. 21, 27-38.
4. Braeuer, R.R., Watson, I.R., Wu, C.J., Mobley, A.K., Kamiya, T., Shoshan, E., and Bar-Eli, M. (2014). Why is melanoma so metastatic? Pigment Cell Melanoma Res. 27, 19-36.
5. Bresnick, A.R., Weber, D.J., and Zimmer, D.B. (2015). S100 proteins in cancer. Nat. Rev. Cancer 15, 96-109.
6. Briscoe, J., and Therond, P.P. (2013). The mechanisms of Hedgehog signalling and its roles in development and disease. Nat. Rev. Mol. Cell Biol. 14, 416-429.
7. Cai, J., Fang, L., Huang, Y., Li, R., Yuan, J., Yang, Y., Zhu, X., Chen, B., Wu, J., and Li, M. (2013). miR-205 targets PTEN and PHLPP2 to augment AKT signaling and drive malignant phenotypes in non-small cell lung cancer. Cancer Res. 73, 5402-5415.
8. Cancer Genome Atlas Research Network, Weinstein, J.N., Collisson, E.A., Mills, G.B., Shaw, K.R., Ozenberger, B.A., Ellrott, K., Shmulevich, I., Sander, C., and Stuart, J.M. (2013). The Cancer Genome Atlas Pan-Cancer analysis project. Nat. Genet. 45, 1113-1120.
9. Damsky, W.E., Curley, D.P., Santhanakrishnan, M. et al. (2011). beta-catenin signaling controls metastasis in Braf-activated Pten-deficient melanomas. Cancer Cell 20, 741-754.
10. Dar, A.A., Majid, S., de Semir, D., Nosrati, M., Bezrookove, V., and Kashani-Sabet, M. (2011). miRNA-205 suppresses melanoma cell proliferation and induces senescence via regulation of E2F1 protein. J. Biol. Chem. 286, 16606-16614.
11. Depianto, D., Kerns, M.L., Dlugosz, A.A., and Coulombe, P.A. (2010). Keratin 17 promotes epithelial proliferation and tumor growth by polarizing the immune response in skin. Nat. Genet. 42, 910-914.
12. Donato, R., Cannon, B.R., Sorci, G., Riuzzi, F., Hsu, K., Weber, D.J., and Geczy, C.L. (2013). Functions of S100 proteins. Curr. Mol. Med. 13, 24-57.
13. Finger, E.C., and Giaccia, A.J. (2010). Hypoxia, inflammation, and the tumor microenvironment in metastatic disease. Cancer Metastasis Rev. 29, 285-293.
14. Friedl, P., and Alexander, S. (2011). Cancer invasion and the microenvironment: plasticity and reciprocity. Cell 147, 992-1009.
15. Garraway, L.A., and Lander, E.S. (2013). Lessons from the cancer genome. Cell 153, 17-37.
16. Geiger, T.R., and Peeper, D.S. (2009). Metastasis mechanisms. Biochim. Biophys. Acta 1796, 293-308.
17. Gray-Schopfer, V., Wellbrock, C., and Marais, R. (2007). Melanoma biology and new targeted therapy. Nature 445, 851-857.
18. Gregory, P.A., Bert, A.G., Paterson, E.L., Barry, S.C., Tsykin, A., Farshid, G., Vadas, M.A., Khew-Goodall, Y., and Goodall, G.J. (2008). The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat. Cell Biol. 10, 593-601.
19. Gross, S.R., Sin, C.G., Barraclough, R., and Rudland, P.S. (2014). Joining S100 proteins and migration: for better or for worse, in sickness and in health. Cell. Mol. Life Sci. 71, 1551-1579.
20. Guan, J., Gupta, R., and Filipp, F.V. (2015). Cancer systems biology of TCGA SKCM: efficient detection of genomic drivers in melanoma. Sci. Rep. 5, 7857.
21. Guo, Q., Su, N., Zhang, J., Li, X., Miao, Z., Wang, G., Cheng, M., Xu, H., Cao, L., and Li, F. (2014). PAK4 kinase-mediated SCG10 phosphorylation involved in gastric cancer metastasis. Oncogene 33, 3277-3287.
22. Halberg, N., Alarcon, C., and Tavazoie, S.F. (2012). microRNA regulation of cancer-endothelial interactions: vesicular microRNAs on the move. EMBO J. 31, 3509-3510.
23. Hodis, E., Watson, I.R., Kryukov, G.V. et al. (2012). A landscape of driver mutations in melanoma. Cell 150, 251-263.
24. Hollander, M., and Wolfe, D.A. (1973). Nonparametric Statistical Methods. (New York, NY: Wiley).
25. Huang da, W., Sherman, B.T., and Lempicki, R.A. (2009). Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 4, 44-57.
26. Karantza, V. (2011). Keratins in health and cancer: more than mere epithelial cell markers. Oncogene 30, 127-138.
27. Komiya, Y., and Habas, R. (2008). Wnt signal transduction pathways. Organogenesis 4, 68-75.
28. Kondratiev, S., Gnepp, D.R., Yakirevich, E., Sabo, E., Annino, D.J., Rebeiz, E., and Laver, N.V. (2008). Expression and prognostic role of MMP2, MMP9, MMP13, and MMP14 matrix metalloproteinases in sinonasal and oral malignant melanomas. Hum. Pathol. 39, 337-343.
29. Larzabal, L., de Aberasturi, A.L., Redrado, M., Rueda, P., Rodriguez, M.J., Bodegas, M.E., Montuenga, L.M., and Calvo, A. (2014). TMPRSS4 regulates levels of integrin alpha5 in NSCLC through miR-205 activity to promote metastasis. Br. J. Cancer 110, 764-774.
30. Lemmon, M.A., and Schlessinger, J. (2010). Cell signaling by receptor tyrosine kinases. Cell 141, 1117-1134.
31. Li, L., Darden, T.A., Weinberg, C.R., Levine, A.J., and Pedersen, L.G. (2001a). Gene assessment and sample classification for gene expression data using a genetic algorithm/k-nearest neighbor method. Comb. Chem. High Throughput Screen. 4, 727-739.
32. Li, L., Weinberg, C.R., Darden, T.A., and Pedersen, L.G. (2001b). Gene selection for sample classification based on gene expression data: study of sensitivity to choice of parameters of the GA/KNN method. Bioinformatics 17, 1131-1142.
33. Li, L., Umbach, D.M., Terry, P., and Taylor, J.A. (2004). Application of the GA/KNN method to SELDI proteomics data. Bioinformatics 20, 1638-1640.
34. Li, C., Finkelstein, D., and Sherr, C.J. (2013). Arf tumor suppressor and miR-205 regulate cell adhesion and formation of extraembryonic endoderm from pluripotent stem cells. Proc. Natl Acad. Sci. USA 110, E1112-E1121.
35. Markiewski, M.M., Deangelis, R.A., Benencia, F., Ricklin-Lichtsteiner, S.K., Koutoulaki, A., Gerard, C., Coukos, G., and Lambris, J.D. (2008). Modulation of the antitumor immune response by complement. Nat. Immunol. 9, 1225-1235.
36. Massague, J. (2012). TGFbeta signalling in context. Nat. Rev. Mol. Cell Biol. 13, 616-630.
37. Matsushima, K., Isomoto, H., Yamaguchi, N. et al. (2011). MiRNA-205 modulates cellular invasion and migration via regulating zinc finger E-box binding homeobox 2 expression in esophageal squamous cell carcinoma cells. J. Transl. Med. 9, 30.
38. Miller, A.J., and Mihm Jr, M.C. (2006). Melanoma. N. Engl. J. Med. 355, 51-65.
39. Moro, N., Mauch, C., and Zigrino, P. (2014). Metalloproteinases in melanoma. Eur. J. Cell Biol. 93, 23-29.
40. Nasser, M.W., Qamri, Z., Deol, Y.S. et al. (2012). S100A7 enhances mammary tumorigenesis through upregulation of inflammatory pathways. Cancer Res. 72, 604-615.
41. Oka, R., Sasagawa, T., Ninomiya, I., Miwa, K., Tanii, H., and Saijoh, K. (2001). Reduction in the local expression of complement component 6 (C6) and 7 (C7) mRNAs in oesophageal carcinoma. Eur. J. Cancer 37, 1158-1165.
42. Omberg, L., Ellrott, K., Yuan, Y., Kandoth, C., Wong, C., Kellen, M.R., Friend, S.H., Stuart, J., Liang, H., and Margolin, A.A. (2013). Enabling transparent and collaborative computational analysis of 12 tumor types within The Cancer Genome Atlas. Nat. Genet. 45, 1121-1126.
43. Pennati, M., Lopergolo, A., Profumo, V., de Cesare, M., Sbarra, S., Valdagni, R., Zaffaroni, N., Gandellini, P., and Folini, M. (2014). miR-205 impairs the autophagic flux and enhances cisplatin cytotoxicity in castration-resistant prostate cancer cells. Biochem. Pharmacol. 87, 579-597.
44. Piovan, C., Palmieri, D., di Leva, G. et al. (2012). Oncosuppressive role of p53-induced miR-205 in triple negative breast cancer. Mol. Oncol. 6, 458-472.
45. Quail, D.F., and Joyce, J.A. (2013). Microenvironmental regulation of tumor progression and metastasis. Nat. Med. 19, 1423-1437.
46. Rutkowski, M.J., Sughrue, M.E., Kane, A.J., Mills, S.A., and Parsa, A.T. (2010). Cancer and the complement cascade. Mol. Cancer Res. 8, 1453-1465.
47. Srivastava, A., Goldberger, H., Dimtchev, A. et al. (2013). MicroRNA profiling in prostate cancer-the diagnostic potential of urinary miR-205 and miR-214. PLoS ONE 8, e76994.
48. Viros, A., Sanchez-Laorden, B., Pedersen, M. et al. (2014). Ultraviolet radiation accelerates BRAF-driven melanomagenesis by targeting TP53. Nature 511, 478-482.
49. Vogelstein, B., Papadopoulos, N., Velculescu, V.E., Zhou, S., Diaz Jr, L.A., and Kinzler, K.W. (2013). Cancer genome landscapes. Science 339, 1546-1558.
50. Wang, Z., Liao, H., Deng, Z., Yang, P., Du, N., Zhanng, Y., and Ren, H. (2013). miRNA-205 affects infiltration and metastasis of breast cancer. Biochem. Biophys. Res. Commun. 441, 139-143.
51. Wu, Y., and Zhou, B.P. (2009). Inflammation: a driving force speeds cancer metastasis. Cell Cycle 8, 3267-3273.
52. Xu, Y., Brenn, T., Brown, E.R., Doherty, V., and Melton, D.W. (2012). Differential expression of microRNAs during melanoma progression: miR-200c, miR-205 and miR-211 are downregulated in melanoma and act as tumour suppressors. Br. J. Cancer 106, 553-561.